Carmat SA

Paris Stock Exchange ALCAR.PA

Carmat SA Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -5.42 M

Carmat SA Net Cash Used For Investing Activities is USD -5.42 M for the year ending December 31, 2023, a -154.79% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Carmat SA Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD -2.13 M, a -6.88% change year over year.
  • Carmat SA Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -1.99 M, a 29.00% change year over year.
  • Carmat SA Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -2.81 M, a -292.92% change year over year.
  • Carmat SA Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -714.13 K, a 72.95% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
Paris Stock Exchange: ALCAR.PA

Carmat SA

CEO Mr. Stephane Piat
IPO Date July 13, 2010
Location France
Headquarters 36, avenue de l'Europe
Employees 162
Sector Consumer Discretionary
Industries
Description

Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.

Similar companies

ALCLS.PA

Cellectis S.A.

USD 1.74

-2.29%

NANO.PA

Nanobiotix S.A.

USD 3.05

0.95%

GNFT.PA

Genfit S.A.

USD 3.40

-0.30%

IPH.PA

Innate Pharma S.A.

USD 1.88

-0.49%

StockViz Staff

January 15, 2025

Any question? Send us an email